Kenya - English - Pharmacy and Poisons Board

united biotech (p) limited fc/b-1 (extn.), mohan co-operative industrial - amphotericin b usp - powder for injection - amphotericin b usp 50 mg per vial - antimycotics for systemic use: antibiotics

Kenya - English - Pharmacy and Poisons Board

intas pharmaceuticals ltd chinubhai centre off. nehru bridge ashram road - amphotericin - injection - amphotericin 50mg - antimycotics for systemic use: antibiotics

Canada - English - Health Canada

cheplapharm arzneimittel gmbh - amphotericin b - powder for solution - 50mg - amphotericin b 50mg - polyenes

Australia - English - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - amphotericin b -

Israel - English - Ministry of Health

gilead sciences israel ltd - amphotericin b - powder for concentrate for infusion - amphotericin b 50 mg/vial - amphotericin b - antifungal antibiotic for the treatment of severe systemic and/or deep mycoses where toxicity precludes the use of conventional systemic amphotericin b in effective dosages. this drug should not be used to treat the common clinically inapparent forms of fungal disease which show only positive skin or serologic tests. ambisome is also indicated for the treatment of systemic fungal infections in immunocompromised patients (e.g. patients with aids or cancer). ambisome is also indicated for the primary therapy of visceral leishmaniasis in immunocompetent patients and immunocompromised patients (e.g. hiv positive). empirical treatment of presumed fungal infection in febrile neutropenic patients.

Israel - English - Ministry of Health

gilead sciences israel ltd - amphotericin b - powder for concentrate for infusion - amphotericin b 50 mg/vial - amphotericin b - antifungal antibiotic for the treatment of severe systemic and/or deep mycoses where toxicity precludes the use of conventional systemic amphotericin b in effective dosages. this drug should not be used to treat the common clinically inapparent forms of fungal disease which show only positive skin or serologic tests. ambisome is also indicated for the treatment of systemic fungal infections in immunocompromised patients (e.g. patients with aids or cancer). ambisome is also indicated for the primary therapy of visceral leishmaniasis in immunocompetent patients and immunocompromised patients (e.g. hiv positive). empirical treatment of presumed fungal infection in febrile neutropenic patients.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

bharat serums and vaccines limited, india - amphotericin b - lyophilized injection - 50 mg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

pahang pharmacy sdn. bhd. - amphotericin b -

Singapore - English - HSA (Health Sciences Authority)

gilead sciences singapore pte. ltd. - amphotericin b - injection, powder, for solution - 50 mg/vial - amphotericin b 50 mg/vial

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

neon healthcare ltd - amphotericin b - powder for solution for infusion - 50mg